Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Which Pharma Stock is a Pick for June: Pfizer (PFE) or SNDL Inc. (SNDL)?

The pharmaceutical industry is known for its resilience during challenging economic times, primarily due to the inelastic demand for essential medicines. As the specter of a potential recession hangs over the market, let us analyze two leading players in the sector, Pfizer (PFE) and SNDL (SNDL), to find the better…

StockNews.com

Merck sues federal government, calling plan to negotiate Medicare drug prices 'extortion'

Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion

The Independent UK

Merck Delivers First Legal Blow To Biden's Medicare Negotiation Plan, Calling It A 'Sham'

Merck sued the Biden administration Tuesday, saying a drug-pricing law is a "sham." The legal battle will impact pharmaceutical stocks.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Pharmaceutical Stocks to Watch

The pharmaceutical industry is anticipated to grow due to rising chronic diseases and an aging population. Given the industry's strong long-term prospects, quality stocks Novo Nordisk (NVO), Novartis (NVS), and Bristol-Myers Squibb (BMY) could be worth adding to your watchlist. Continue reading….

StockNews.com

Magnitude Biosciences seals £500,000 investment to ramp up research work

It has secured a Future Economy Investor Partnerships grant from Innovate UK which has been match funded by the North East Innovation Fund

Birmingham Post

Is a Possible Delta-8 THC Ban in the Works? This Week in Cannabis Investing

The Drug Enforcement Agency is reportedly planning to reschedule many hemp-derived cannabinoids, including delta-8 THC.

Kiplinger

IBD 50 Stock Hits All-Time High, And 44% EPS Growth Expected

This drug stock ranks first out of 790 medical stocks and is in the buy zone. The company plans to roll out its overdose nasal spray in the third quarter.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Supreme Court revives claims that SuperValu, Safeway overcharged governments for generic drugs

The Supreme Court has unanimously revived whistleblower lawsuits claiming that supermarket and pharmacy chains SuperValu and Safeway overcharged government health-care programs for prescription drugs by hundreds of millions of dollars

The Independent UK

Biogen Hits Buy Zone On A Fresh Win For Its Alzheimer's Treatment; Eli Lilly, Eisai Shares Jump

Biogen stock jumped into a buy zone Thursday after Medicare officials said they would pay for some Alzheimer's treatments.

Investors Business Daily

Biohaven, A Top 2% Stock, Exits 'Stealth Mode' And Hits A Record High

Biohaven is coming "out of stealth mode," an analyst said Thursday as BHVN stock climbed for a fourth consecutive day.

Investors Business Daily

LOCALIZE IT: State and local governments figuring out how to use opioid settlement money

EDITORS/NEWS DIRECTORS:

The Independent UK

Merck makes €35 million investment in Scottish sites

The expansion plan should create nearly 500 new jobs in Glasgow and Stirling

Insider UK

Elizabeth Holmes Reporting To Jail Today, And The Dropout’s Amanda Seyfried Shared Her Take

Theranos founder Elizabeth Holmes' prison sentence is finally starting, and her portrayer in The Dropout, Amanda Seyfried, shared her thoughts.

Cinemablend

AbbVie (ABBV) and Catalyst Pharmaceuticals (CPRX): Analyzing Investment Potential

The pharmaceutical industry’s inelastic demand for its products helps it to weather economic downturns. With fears of an impending recession playing on the minds of investors, it could be wise to buy fundamentally strong pharmaceutical stock AbbVie (ABBV). On the other hand, given its mixed fundamentals and profitability, it could…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

A landmark appeals court ruling clears way for Purdue Pharma-Sackler bankruptcy deal

The 2nd Circuit Court of Appeals in New York cleared the way for a controversial bankruptcy deal that grants immunity from opioid lawsuits to members of the Sackler family.

The Guardian - US

‘I yelled, “I’m putting this up your nose”’: what it’s like to use Narcan

Four people on using the nostril-based antidote to opioid overdoses, newly approved for over-the-counter sale

StockNews.com

CVS Health (CVS) vs. MedAvail Holdings (MDVL): Which Is the Better Buy?

The drug store industry is well positioned for long-term growth thanks to the growing demand for prescription drugs. Let’s compare CVS Health (CVS) and MedAvail (MDVL) in this space to determine which is better positioned to capitalize on the industry’s solid growth prospects….

Nottingham Post

The Nottinghamshire pharmacies which failed to meet all standards during inspections

"Whilst the national report looked pretty daunting I’ve not found anything for significant cause for concern"

Get all your
news in one place.

100’s of premium titles.
One news app.

The National (Scotland)

UK response to Covid pandemic was 'fuelled by nationalism'

THE UK’S response to the Covid pandemic has been branded “colonial” and “fuelled by nationalism” by justice campaigners.

The Independent UK

Oregon, awash in treatment funds after decriminalizing drugs, now must follow the money

Funding for drug treatment centers in Oregon, financed by the state’s pioneering drug decriminalization policy, stands these days at over a quarter-billion dollars

Daily Mirror

US drug firm loses license after ignoring suspiciously large painkiller orders during opioid crisis

Morris & Dickson Co.'s license has been revoked by the US Drug Enforcement Administration (DEA) following a 68-page order by DEA Administrator Anne Milgram on the opioid crisis

Investors Business Daily

Eli Lilly Could Launch Its Rival To Novo Nordisk's Weight-Loss Drug A Year Earlier Than Expected

An analyst expects Lilly to launch a competitor in weight-loss drugs a year earlier than expected, giving Eli Lilly stock a chance to shine.

WEKU

DEA moves to revoke major drug distributor's license over opioid crisis failures

The agency says it will strip Morris & Dickson of its license to sell highly addictive painkillers after finding it failed to flag thousands of suspicious orders at the height of the opioid crisis.

Investors Business Daily

Arcus, Iteos Soar On Roche's 'Meaningful' Results In A New Cancer Drug Class

Shares of Arcus and Iteos surged Friday after Roche provided "meaningful" evidence for a new cancer treatment class.

The Independent UK

After yearslong delay, DEA revokes license of wholesale drug distributor over opioid crisis failures

The U.S. Drug Enforcement Administration has stripped one of the nation’s largest pharmaceutical distributors of its license to sell highly addictive painkillers after determining it failed to flag thousands of suspicious, high-volume orders at the height of the opioid crisis

1 … 47 48 49 50

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.